Loading company…
Yemaachi Biotech develops cancer diagnostics and research services, including molecular testing.
Founded in 2020 and based in Accra, Ghana, Yemaachi Biotech develops cancer diagnostics and research services. Its offerings include COVID-19 testing, HPV self-sampling and cervical cancer testing, and NGS-based screening and prognostic testing. It works with pharmaceutical and biotechnology companies on diagnostics and therapeutics. V8 Ventures and Lifeline Financial Group, LoftyInc Capital Management, Tencent Investment, VestedWorld, VSquare Capital, and Y Combinator provided USD 3 million in seed funding in March 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in